Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-26 @ 2:09 AM
Study NCT ID:
NCT05215405
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2025-02-03
First Post:
2022-01-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LL
Sponsor:
Kathleen Ludwig
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2022-01-17
First Submit QC Date:
None
Study First Post Date:
2022-01-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-29
Last Update Post Date:
2025-02-03
Last Update Post Date Type:
ACTUAL